The overall goal for patient selection for spinal cord stimulation is to choose those patients most likely to experience therapeutic success while reducing the likelihood of risks, complications, and adverse events. A careful assessment by a multidisciplinary team, and discussion of the patient's expectations and goals, will help identify appropriate candidates for spinal cord stimulation.
Spinal Cord Stimulation is an aid in the management of chronic, intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with the following conditions:
The safety and effectiveness of this therapy has not been established for pregnancy, unborn fetus or delivery.
If a patient does not respond well to neurostimulation, he or she may be a candidate for Targeted Drug Delivery.
Spinal cord stimulation may benefit certain patients who meet the following criteria:
A screening trial allows patients to assess their response to spinal cord stimulation prior to device implantation. Patients who experience adequate pain relief from the screening trial may be candidates for an implanted neurostimulation system.
The screening trial:
Medtronic offers standardized guidance for trialing spinal cord stimulation, including DTM™ SCS Therapy, a proprietary therapy of Medtronic.